EP0651993 - PERCUTANEOUSLY ADMINISTRABLE BASE COMPOSITION AND DRUG COMPOSITION PREPARED THEREFROM [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 15.08.2003 Database last updated on 19.10.2024 | Most recent event Tooltip | 15.08.2003 | No opposition filed within time limit | published on 01.10.2003 [2003/40] | Applicant(s) | For all designated states Hisamitsu Pharmaceutical Co., Inc. 408, Tashirodaikanmachi Tosu-shi, Saga 841 / JP | [N/P] |
Former [2002/41] | For all designated states HISAMITSU PHARMACEUTICAL CO., INC. 408, Tashirodaikanmachi Tosu-shi Saga 841 / JP | ||
Former [1995/19] | For all designated states HISAMITSU PHARMACEUTICAL CO. INC. 408, Tashirodaikanmachi Tosu-shi Saga 841 / JP | Inventor(s) | 01 /
HIGO, Naruhito, Tsukuba Institute of Hisamitsu Pharmaceutical Co. Inc., 25-11, Kannondai 1-chome Tsukuba-shi, Ibaragi 305 / JP | 02 /
KOJIMA, Yukio, Tsukuba Institute of Hisamitsu Pharmaceutical Co. Inc., 25-11, Kannondai 1-chome Tsukuba-shi, Ibaragi 305 / JP | 03 /
KOMORI, Ken-ichi, Tsukuba Institute of Hisamitsu Pharmaceutical Co. Inc., 25-11, Kannondai 1-chome Tsukuba-shi, Ibaragi 305 / JP | [1995/19] | Representative(s) | Webber, Philip Michael Dehns St Bride's House 10 Salisbury Square London EC4Y 8JD / GB | [N/P] |
Former [2002/27] | Webber, Philip Michael Frank B. Dehn & Co., 179 Queen Victoria Street London EC4V 4EL / GB | ||
Former [1996/33] | Pett, Christopher Phineas Frank B. Dehn & Co., European Patent Attorneys, 179 Queen Victoria Street London EC4V 4EL / GB | ||
Former [1995/19] | Matthews, Derek Peter, et al Frank B. Dehn & Co. Imperial House 15-19 Kingsway London WC2B 6UZ / GB | Application number, filing date | 93916216.0 | 23.07.1993 | [1995/19] | WO1993JP01034 | Priority number, date | JP19920218369 | 23.07.1992 Original published format: JP 21836992 | JP19920229226 | 04.08.1992 Original published format: JP 22922692 | [1995/19] | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO9402119 | Date: | 03.02.1994 | Language: | EN | [1994/04] | Type: | A1 Application with search report | No.: | EP0651993 | Date: | 10.05.1995 | Language: | EN | The application published by WIPO in one of the EPO official languages on 03.02.1994 takes the place of the publication of the European patent application. | [1995/19] | Type: | B1 Patent specification | No.: | EP0651993 | Date: | 09.10.2002 | Language: | EN | [2002/41] | Search report(s) | International search report - published on: | JP | 03.02.1994 | (Supplementary) European search report - dispatched on: | EP | 06.01.1997 | Classification | IPC: | A61K9/00, A61K47/10, A61K47/26, A61K47/14 | [1997/04] | CPC: |
A61K9/0014 (EP,US);
A61K47/10 (EP,US);
A61P11/10 (EP);
A61P11/14 (EP);
A61P21/02 (EP);
A61P23/00 (EP);
|
Former IPC [1995/19] | A61K9/00 | Designated contracting states | AT, BE, CH, DE, ES, FR, GB, IT, LI, NL, SE [1995/19] | Title | German: | PERKUTAN VERABREICHBARE BASISZUSAMMENSETZUNG UND DARAUS HERGESTELLTE ZUSAMMENSETZUNG | [2001/48] | English: | PERCUTANEOUSLY ADMINISTRABLE BASE COMPOSITION AND DRUG COMPOSITION PREPARED THEREFROM | [1995/19] | French: | COMPOSITION DE BASE POUR ADMINISTRATION PERCUTANEE ET COMPOSITION DE MEDICAMENT DERIVEE DE CELLE-CI | [2001/48] |
Former [1995/19] | PERKUTAN VERABREICHBARE BASISZUSAMMENSETZUNG UND DAVON HERGESTELLTE ZUSAMMENSETZUNG | ||
Former [1995/19] | COMPOSITION DE BASE ADMINISTRABLE PAR INJECTION PERCUTANEE ET COMPOSITION DE MEDICAMENT DERIVEE | Entry into regional phase | 17.02.1995 | Translation filed | 17.02.1995 | National basic fee paid | 17.02.1995 | Search fee paid | 17.02.1995 | Designation fee(s) paid | 17.02.1995 | Examination fee paid | Examination procedure | 22.11.1993 | Request for preliminary examination filed International Preliminary Examining Authority: JP | 17.02.1995 | Examination requested [1995/19] | 29.11.1999 | Despatch of a communication from the examining division (Time limit: M06) | 08.06.2000 | Reply to a communication from the examining division | 25.08.2000 | Despatch of a communication from the examining division (Time limit: M06) | 12.04.2001 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time | 21.06.2001 | Reply to a communication from the examining division | 30.11.2001 | Despatch of communication of intention to grant (Approval: No) | 09.04.2002 | Despatch of communication of intention to grant (Approval: later approval) | 25.04.2002 | Communication of intention to grant the patent | 05.08.2002 | Fee for grant paid | 05.08.2002 | Fee for publishing/printing paid | Opposition(s) | 10.07.2003 | No opposition filed within time limit [2003/40] | Request for further processing for: | 21.06.2001 | Request for further processing filed | 21.06.2001 | Full payment received (date of receipt of payment) Request granted | 05.07.2001 | Decision despatched | Fees paid | Renewal fee | 25.07.1995 | Renewal fee patent year 03 | 22.07.1996 | Renewal fee patent year 04 | 28.07.1997 | Renewal fee patent year 05 | 27.07.1998 | Renewal fee patent year 06 | 26.07.1999 | Renewal fee patent year 07 | 26.07.2000 | Renewal fee patent year 08 | 25.07.2001 | Renewal fee patent year 09 | 24.07.2002 | Renewal fee patent year 10 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]US4719239 (MULLER BERND W W [DE], et al); | [A]WO9207590 (ALZA CORP [US]) [A] 6 * claims 8,9 * | International search | [XY]JPH02115131 (THERATECH INC [US]) |